JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davie, C A
Right arrow Articles by Miller, D H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davie, C A
Right arrow Articles by Miller, D H
Topic Collections
Right arrowRelevant Article
J Neurol Neurosurg Psychiatry 1999;67:710-715 ( December )

Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?

C A Davie, N C Silver, G J Barker, P S Tofts, A J Thompson, W I McDonald, D H Miller

NMR Research Unit. Institute of Neurology, Queen Square, London WC1N 3BG, UK

Correspondence to: Professor D H Miller, NMR Research Unit. Institute of Neurology, Queen Square, London WC1N 3BG, UK. Telephone 0044 171 278 5616.

Received 16 June 1998 and in revised form 4 March 1999; Accepted 18 March 1999

OBJECTIVE---To determine non-invasively the relation between the degree of axonal loss and the extent of demyelination in chronic lesions visible on MRI in patients with different subgroups of clinically definite multiple sclerosis using 1H magnetic resonance spectroscopy (1H MRS) and magnetisation transfer imaging (MT). Conventional MRI is unable to differentiate between the various pathological processes occurring in the multiple sclerosis lesion. There are, however, newer MR techniques which show promise in this respect.
METHODS--- 1H MRS and MT were performed in 18 patients with clinically definite multiple sclerosis who had a wide range of disability and disease duration.
RESULTS---A significant correlation was found between a reduction in the concentration of N-acetyl aspartate (NAA; an in vivo marker of axonal loss or dysfunction) and a reduction in MT ratio (a probable marker of demyelination) in patients who had entered the secondary progressive stage of the disease. Patients with minimal disability after a disease duration of greater than 10 years---so called benign multiple sclerosis---showed a relative preservation of NAA and MT.
CONCLUSIONS---Because a reduction in MT seems to be a relative marker for demyelination and a reduction of NAA from chronic lesions is indicative of axonal loss, this study supports the hypothesis that demyelination and axonal loss occur in the same chronic multiple sclerosis lesions. In addition, the degree of axonal loss and demyelination correlates with clinical heterogeneity.


Keywords: magnetisation transfer; 1H magnetic resonance spectroscopy; N-acetyl aspartate; multiple sclerosis


© 1999 by Journal of Neurology, Neurosurgery, and Psychiatry

Relevant Article

Axonal loss and demyelation in multiple sclerosis
P M MATTHEWS
J. Neurol. Neurosurg. Psychiatry 1999 67: 708-709. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
NeurologyHome page
M. P. Amato, E. Portaccio, M. L. Stromillo, B. Goretti, V. Zipoli, G. Siracusa, M. Battaglini, A. Giorgio, M. L. Bartolozzi, L. Guidi, et al.
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis
Neurology, August 26, 2008; 71(9): 632 - 638.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. Lindquist, N. Bodammer, J. Kaufmann, F. Konig, H.-J. Heinze, W. Bruck, and M. Sailer
Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant
Multiple Sclerosis, May 1, 2007; 13(4): 471 - 482.
[Abstract] [PDF]


Home page
BrainHome page
N. De Stefano, M. Battaglini, M. L. Stromillo, V. Zipoli, M. L. Bartolozzi, L. Guidi, G. Siracusa, E. Portaccio, A. Giorgio, S. Sorbi, et al.
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis
Brain, August 1, 2006; 129(8): 2008 - 2016.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
W. Staffen, H. Zauner, A. Mair, A. Kutzelnigg, P. Kapeller, H. Stangl, E. Raffer, H. Niederhofer, and G. Ladurner
Magnetic Resonance Spectroscopy of Memory and Frontal Brain Region in Early Multiple Sclerosis
J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 357 - 363.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S K Ludwin
Pathologic Classification Systems in MS: What is their Significance?
Multiple Sclerosis, February 1, 2005; 11(1): 106 - 107.
[PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Symms, H R Jager, K Schmierer, and T A Yousry
A review of structural magnetic resonance neuroimaging
J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1235 - 1244.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. S.M. Ramsaransing, A. Teelken, A. V. Arutjunyan, and J. De Keyser
Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course
Neurology, January 27, 2004; 62(2): 239 - 242.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. Enzinger, S. Ropele, S. Strasser-Fuchs, P. Kapeller, H. Schmidt, B. Poltrum, R. Schmidt, H.-P. Hartung, and F. Fazekas
Lower Levels of N-Acetylaspartate in Multiple Sclerosis Patients With the Apolipoprotein E {epsilon}4 Allele
Arch Neurol, January 1, 2003; 60(1): 65 - 70.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. Kuhlmann, G. Lingfeld, A. Bitsch, J. Schuchardt, and W. Bruck
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
Brain, October 1, 2002; 125(10): 2202 - 2212.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
E. A. DeSousa, R. H. Albert, and B. Kalman
Cognitive impairments in multiple sclerosis: A review
American Journal of Alzheimer's Disease and Other Dementias, January 1, 2002; 17(1): 23 - 29.
[Abstract] [PDF]


Home page
Mult SclerHome page
G. Ramsaransing, N. Maurits, C. Zwanikken, and J. De Keyser
Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review
Multiple Sclerosis, October 1, 2001; 7(5): 345 - 347.
[Abstract] [PDF]


Home page
Arch NeurolHome page
N. De Stefano, S. Narayanan, G. S. Francis, R. Arnaoutelis, M. C. Tartaglia, J. P. Antel, P. M. Matthews, and D. L. Arnold
Evidence of Axonal Damage in the Early Stages of Multiple Sclerosis and Its Relevance to Disability
Arch Neurol, January 1, 2001; 58(1): 65 - 70.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P A Brex, G J M Parker, S M Leary, P D Molyneux, G J Barker, C A Davie, A J Thompson, and D H Miller
Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations
J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 627 - 632.
[Abstract] [Full Text]


Home page
BrainHome page
T. Revesz
Axonal lesions in multiple sclerosis: an old story revisited
Brain, February 1, 2000; 123(2): 203 - 204.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P M MATTHEWS
Axonal loss and demyelation in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 708 - 709.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd.